Piers Ingram, Founder of Callio Therapeutics

Piers Ingram is the founder of Callio Therapeutics. Callio Therapeutics has raised $187M, latest Series A $187M (2025). Biotech · Seattle, WA.

About Piers Ingram

Piers Ingram is the founder of Callio Therapeutics. Callio Therapeutics operates in Biotech and is based in Seattle, WA. Callio Therapeutics has raised $187M, latest Series A $187M (2025). Backers on record include Irem Rami, Jeff Crowe, Tejas Maniar, Mayfield Fund, Norwest, Norwest Venture Partners.

Piers Ingram at a glance

Company
Callio Therapeutics
Industry
Biotech
Location
Seattle, WA
Total raised
$187M
Investors on record
Irem Rami, Jeff Crowe, Tejas Maniar, Mayfield Fund, Norwest, Norwest Venture Partners

Frequently asked about Piers Ingram

Who is Piers Ingram?
Piers Ingram is the founder of Callio Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Piers Ingram found?
Piers Ingram founded Callio Therapeutics, a Biotech company based in Seattle, WA.
How do I contact Piers Ingram?
Verified contact routes including LinkedIn, background and funding history for Piers Ingram are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Seattle — who backed them, at what stage, and how much they raised.

Callio Therapeutics funding profile (1)

More Biotech founders (40)

Browse related founder lists (9)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades